Literature DB >> 11000655

End-of-life conversations: evolving practice and theory.

D G Larson1, D R Tobin.   

Abstract

This article examines the evolution of and need for "end-of-life conversations." Barriers to end-of-life discussions that have been identified in patients and families, health care professionals, and health care systems can seriously interfere with the quality of remaining life for terminally ill patients. Strategies for enhancing end-of-life discussions are most productively linked to (1) physicians' interpersonal communication skills, (2) a patient-centered model of care, (3) a focus on quality of remaining life, and (4) innovative clinical models for implementing these discussions earlier in the care process. We conclude that end-of-life conversations must become a routine, structured intervention in health care and that advance care planning is best viewed as one component in a series of ongoing end-of-life discussions. Randomized trials are needed to examine new approaches and models for enhancing end-of-life conversations. JAMA. 2000;284:1573-1578.

Entities:  

Keywords:  Death and Euthanasia; Professional Patient Relationship

Mesh:

Year:  2000        PMID: 11000655     DOI: 10.1001/jama.284.12.1573

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  33 in total

1.  Communication and decision making about life-sustaining treatment: examining the experiences of resident physicians and seriously-ill hospitalized patients.

Authors:  Kristy S Deep; Charles H Griffith; John F Wilson
Journal:  J Gen Intern Med       Date:  2008-09-18       Impact factor: 5.128

2.  Recognising the elephant in the room: Foundation doctors and anticipatory care planning.

Authors:  Helen Chapman; Miriam Jassam; Rebecca O'Rourke; Rebecca Anthony
Journal:  Future Healthc J       Date:  2021-03

3.  Treating chronically ill people with diabetes mellitus with limited life expectancy: implications for performance measurement.

Authors:  LeChauncy D Woodard; Cassie R Landrum; Tracy H Urech; Jochen Profit; Salim S Virani; Laura A Petersen
Journal:  J Am Geriatr Soc       Date:  2012-01-19       Impact factor: 5.562

4.  Primary care availability and emergency department use by older adults: a population-based analysis.

Authors:  Katherine M Hunold; Natalie L Richmond; Anna E Waller; Malcolm P Cutchin; Paul R Voss; Timothy F Platts-Mills
Journal:  J Am Geriatr Soc       Date:  2014-08-14       Impact factor: 5.562

5.  Association between advanced cancer patient-caregiver agreement regarding prognosis and hospice enrollment.

Authors:  Kelly M Trevino; Holly G Prigerson; Megan Johnson Shen; Daniel J Tancredi; Guibo Xing; Michael Hoerger; Ronald M Epstein; Paul R Duberstein
Journal:  Cancer       Date:  2019-05-30       Impact factor: 6.860

6.  Living with advanced illness: longitudinal study of patient, family, and caregiver needs.

Authors:  Karen Tallman; Ruth Greenwald; Alice Reidenouer; Laurel Pantel
Journal:  Perm J       Date:  2012

7.  Racial Disparities in Health Care Utilization at the End of Life Among New Jersey Medicaid Beneficiaries With Advanced Cancer.

Authors:  Annie Yang; David Goldin; Jose Nova; Jyoti Malhotra; Joel C Cantor; Jennifer Tsui
Journal:  JCO Oncol Pract       Date:  2020-04-16

8.  When silence is not golden: Engaging adolescents and young adults in discussions around end-of-life care choices.

Authors:  Lori Wiener; Sima Zadeh; Leonard H Wexler; Maryland Pao
Journal:  Pediatr Blood Cancer       Date:  2013-03-11       Impact factor: 3.167

9.  Allowing adolescents and young adults to plan their end-of-life care.

Authors:  Lori Wiener; Sima Zadeh; Haven Battles; Kristin Baird; Elizabeth Ballard; Janet Osherow; Maryland Pao
Journal:  Pediatrics       Date:  2012-10-08       Impact factor: 7.124

10.  Conflict in the care of patients with prolonged stay in the ICU: types, sources, and predictors.

Authors:  David M Studdert; Michelle M Mello; Jeffrey P Burns; Ann Louise Puopolo; Benjamin Z Galper; Robert D Truog; Troyen A Brennan
Journal:  Intensive Care Med       Date:  2003-07-19       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.